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a b s t r a c t
Castleman’s disease is a rare clinicopathological entity characterized by non-neoplastic lymph node
hypertrophy. Its incidence and etiology is unknown. It has been found in association with Kaposi’s sar-ccepted 26 June 2010
eyword:
astleman’s disease
aposi’s sarcoma
coma thus necessitating investigations for HIV. Although its localized variety is benign other types can
be multifocal with adverse systemic manifestations. A case report of a 42 yrs old female with a slowly
enlarging highly vascular mass in the left iliac fossa is presented which lead to a histological diagnosis of
this rare condition (see picture). Furthermore its clinical features, its types, relevant investigations and
current treatment modalities are discussed.
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. Case report
A 42-yr old female presented with a history of a slowly growing
ass in her left iliac fossa for 2 yrs. She was largely asymp-
omatic except for occasional discomfort around themass. Her past
edical and family history was non-speciﬁc. On examination a
on-tender, ﬁrm mass was palpated but there was no generalised
ymphadenopathyor organomegaly. All her blood resultswerenor-
al including those for abnormal hormone production. AMRI scan
evealed a highly vascular, 6.6 cm×4.6 cm mass lying just anterior
o the left external iliac artery, possibly lymphoid in nature (Fig. 1).
A surgical excision of the mass was carried out under general
naesthetic andhistopathology showedhyaline variant of localized
astleman’s disease. The patient was referred to a hematologist.
ests for HIV and HHV 8 were done, both of which were nega-
ive. The patient remains asymptomatic 8 months post op with no
urther lymph node enlargement.
. Discussion
Castleman’s disease is an uncommon clinicopathological entity
haracterized by non-neoplastic lymph node hypertrophy and
istologically characterized by angiofollicular lymph node hyper-
lasia. Castlemanetalﬁrstdescribed it in1956 inagroupofpatients
ith localized benign lymphadenopathy.1
The incidence is not known and can occur at any age, though it
as mostly been reported in adults in the literature.
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Etiology of this disease is unknown, though it has been found in
association with Kaposi’s sarcoma.
Synonyms
• Angiofollicular lymph node hyperplasia
• Angiofollicular lymphoid hyperplasia
• Giant lymph node hyperplasia
• Lymphoid hamartoma
• Benign lymphoma
Types
Clinically the disease has 2 forms:
1. Localized as ﬁrst described by Castleman, which is more com-
mon.
2. Multicentric disease (MCD) with involvement of several sites,
which was ﬁrst described by Gaba et al. in 1972.2
Histologically the main types are:
• The hyaline vascular type characterized by lymphoid follicular
proliferation at different levels of maturity, often forming a lay-
ered or ‘onionskin’ pattern surrounding a hyalinised vessel at the
center of the follicle. These vessels are often prominent and reac-
tive. This is more commonly seen in the localized form of the
disease.
• The plasma cell variant has sheets of mature plasma cells within
Open access under CC BY-NC-ND license.the interfollicular tissues surrounding larger germinal centers
and has signiﬁcantly less vascularity. The multicentric form of
the disease is nearly always associated with this variant.
• A third histological variant showing a mixed picture can also be
seen in MCD.
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4. Oksenhendler E, Boulanger E, Galicier L, et al. High incidence of Kaposiig. 1. MRI scan revealed a 6.6 cm×4.6 cm vascular mass, a likely lymphoid lesion,
ust anterior to the left external iliac artery.
.1. Clinical features and investigations
The localized form of the disease ismostly asymptomatic with a
ingle site lymph node enlargement. The sites commonly involved
re abdomen, peripheral lymph nodes and the mediastinum. It is
ften discovered incidentally during routine examination, chest X
ays or due to discomfort secondary to local compression as is in
ur case described above. Diagnosis ismadebyhistological analysis
f the lymph node biopsy to distinguish it from a thymoma.
MCD, however, presents with systemic symptoms along with
ultiple lymph node hyperplasia. The systemic symptoms are
hought to be primarily a consequence of elevated Interleukin-
(IL-6) production. They present as asthenia, weight loss, fever,
olyadenopathy with a mean of four-site involvement and is often
ssociated with hepatosplenomegaly.
Some formsofMCDhavebeen found inassociationwithKaposi’s
arcoma, which develops in the clinical course ofmost HIV positive
CD cases3. An association with HIV negative Kaposi’s sarcoma
as also been seen to a much lesser extent. HIV positive MCD
hows an increased prevalence of pulmonary symptoms and can
e differentiated from other types of HIV-associated systemic lym-
hoproliferative disorders. There is also an increased progression
f HIV positiveMCD to HHV 8 associatedmalignant non-Hodgkin’s
ymphoma4.
Routine blood tests usually reveal anaemia, raised ESR, throm-
ocytopenia and raised polyclonal gamma globulins. Identifying an
mmunophenotypically varied population of B-lymphocytes with
olyclonal surface and cytoplasmic immunoglobulinmarkers helps
o conﬁrm the diagnosis of Castleman’s disease and differentiate
t from lymphoma5. HIV testing should be undertaken with the
atient’s permission. Herpes Virus (HHV 8/KSHV) has been isolated
n almost all cases of HIV associated Kaposi’s sarcoma MCD and
ome non HIV Kaposi’s sarcoma MCD prompting tests for KSHV3.
istological examination of the biopsied lymph node is essential
or the diagnosis.
These ﬁndings suggest two possibilities concerning the genesis
f CD:gery Case Reports 1 (2010) 25–26
• Opportunistic presence of HHV 8, favoured by immune perturba-
tions.
• Directpathogenic roleofHHV8, in associationwithdysregulation
of cytokines.
2.2. Treatment
Localized CD usually has a good prognosis and requires surgical
excision of the enlarged lymphnodewith no further treatment. The
patients generally remain asymptomatic thereafter.
MCD however tends to have a variable prognosis with no
documented treatment consensus. A variety of combination treat-
ments have been tried with surgical excision, chemotherapy and
steroids. In patients with associated Kaposi’s sarcoma monthly
polychemotherapy (e.g. cyclophosphamide, vincristine, doxoru-
bicin and prednisone) has been tried with limited success. Anti-IL
6 antibodies have shown success with systemic symptoms, as
have steroids.Most treatmentmodalities involve immunosuppres-
sion, increasing the chances of opportunistic infections. Recent
suggestions are that treatmentwith the antiherpesvirus drug gang-
ciclovir or the antiCD20B cellmonoclonal antibody, rituximab,may
markedly improve outcome.
3. Conclusion
The aim of this discussion is to revisit this very uncommon
condition and emphasis the importance of histology to seal the
diagnosis from other lymphoproliferative conditions. Its asso-
ciation with Kaposi’s sarcoma and the high prevalence of HIV
necessitate investigating this condition.
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